Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Influence of genetics on tumoral pathologies: the example of the adenocarcinoma arising in Barrett's esophagus.

Villanacci V, Bassotti G, Salemme M, Rossi E.

Rev Esp Enferm Dig. 2012 Dec;104(11):592-602. Review.

2.

[Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].

Mokrowiecka A, Wierzchniewska-Ɓawska A, Smolarz B, Romanowicz-Makowska H, Malecka-Panas E.

Pol Merkur Lekarski. 2009 May;26(155):385-9. Polish.

PMID:
19606680
3.

Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.

Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ.

Am J Gastroenterol. 2002 Aug;97(8):1930-6.

PMID:
12190156
4.

Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.

Beilstein M, Silberg D.

Gastroenterol Clin North Am. 2002 Jun;31(2):461-79, ix. Review.

PMID:
12134613
5.

Risk factors, DNA damage, and disease progression in Barrett's esophagus.

Olliver JR, Hardie LJ, Gong Y, Dexter S, Chalmers D, Harris KM, Wild CP.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):620-5.

6.

Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV.

Am J Gastroenterol. 2005 Jun;100(6):1257-64.

PMID:
15929754
7.

The molecular biology of esophageal adenocarcinoma.

Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN.

J Surg Oncol. 2005 Dec 1;92(3):169-90. Review.

PMID:
16299787
8.

Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.

Levine DS, Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS.

Gastroenterology. 1989 Feb;96(2 Pt 1):355-67.

PMID:
2910757
9.

Surgical management of Barrett's esophagus.

Clark GW, DeMeester TR.

Ann Chir Gynaecol. 1995;84(2):139-44. Review.

PMID:
7574371
10.

Molecular targets for treatment of Barrett's esophagus.

Feagins LA, Souza RF.

Dis Esophagus. 2005;18(2):75-86. Review.

PMID:
16053481
11.

Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus.

Dolan K, Morris AI, Gosney JR, Field JK, Sutton R.

J Gastroenterol Hepatol. 2003 Jun;18(6):683-9.

PMID:
12753151
12.
13.

Is Barrett's metaplasia the source of adenocarcinomas of the cardia?

Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, Hinder RA, Bremner CG, DeMeester TR.

Arch Surg. 1994 Jun;129(6):609-14.

PMID:
8204035
14.

[The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].

Endzinas Z, Mickevicius A, Kiudelis M.

Zentralbl Chir. 2004 Apr;129(2):99-103. German.

PMID:
15106039
15.

Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.

Whitson MJ, Falk GW.

Gastroenterol Clin North Am. 2015 Jun;44(2):299-315. doi: 10.1016/j.gtc.2015.02.005. Epub 2015 Mar 31. Review.

16.

Molecular markers and genetics in cancer development.

Hormi-Carver K, Souza RF.

Surg Oncol Clin N Am. 2009 Jul;18(3):453-67. doi: 10.1016/j.soc.2009.03.002. Review.

PMID:
19500736
17.

Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.

Sarr MG, Hamilton SR, Marrone GC, Cameron JL.

Am J Surg. 1985 Jan;149(1):187-93.

PMID:
3966636
18.

Barrett's esophagus: a surgical disease.

Patti MG, Arcerito M, Feo CV, Worth S, De Pinto M, Gibbs VC, Gantert W, Tyrrell D, Ferrell LF, Way LW.

J Gastrointest Surg. 1999 Jul-Aug;3(4):397-403; discussion 403-4.

PMID:
10482692
19.

Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.

Rygiel AM, Milano F, Ten Kate FJ, Schaap A, Wang KK, Peppelenbosch MP, Bergman JJ, Krishnadath KK.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1380-5. doi: 10.1158/1055-9965.EPI-07-2734.

20.

Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.

Agarwal B, Swisher SG, Ajani J, Kelly K, Komaki RR, Abu-Hamda E, Correa AM, Roth JA.

Ann Thorac Surg. 2005 May;79(5):1716-23.

PMID:
15854962

Supplemental Content

Support Center